CENTOGENE

🧬 Nos complace anunciar nuestro nuevo CENTOGENE Webinar: Generando evidencia: claves para una Medicina de Precisión en Neuropediatría Estamos muy ilusionados de contar con la participación de grandes referentes en el ámbito de la neuropediatría y la genética, con quienes compartiremos una sesión que no te puedes perder: 🎙️Alberto Fernández Jaén, ponente 🎙️Eva Barroso Ramos, ponente 👥Javier García Planells, moderador 📅 Miércoles, 7 de octubre de 2026 🕖 19:00 Madrid | 14:00 Buenos Aires | 12:00 Bogotá | 11:00 Ciudad de México Seguimos trabajando para acercar la Medicina de Precisión a quienes más lo necesitan. 💙 👉 Reserva tu plaza: https://lnkd.in/eRQ54kKV ¡Te esperamos! #CENTOGENE #MedicinaDePrecisión #Neuropediatría #Genética #Webinar

We are excited to share that CENTOGENE will present three scientific posters at ASHG 2026, exploring how genome sequencing can address that challenge across different clinical settings: hereditary ataxias caused by repeat expansions, reproductive carrier screening for complex gene variants, and rare disease diagnostics in challenging variant contexts. 📍 Palais des Congrès de Montréal 👋 Visit us at Booth #1301 during the congress to discuss the work with our experts. We look forward to exchanging ideas with researchers, clinicians and industry colleagues on how genomic diagnostics can bring more patients closer to an answer. Swipe through to see the full program. #CENTOGENE #ASHG2026 #HumanGenetics #Genomics #PrecisionMedicine #RareDisease #GenomeSequencing #CarrierScreening #Neurogenetics

We are excited to announce that CENTOGENE will be participating in the ASHG 2026 Annual Meeting, the premier global gathering for the human genetics and genomics community. As one of the largest international events in human genetics and genomics, ASHG brings together researchers, clinicians, and industry leaders to exchange knowledge and explore the latest scientific and technological advances shaping the field. This year, 5 members of our team will be attending, and we look forward to connecting with colleagues and partners across the community. Our team attending: Louis Panagopoulos, VP Market Access & Business Development Dx Peter Bauer, Chief Medical & Genomic Officer Jorge Pinto Basto, VP Medical Genetics Eleni Perraki, PhD, Senior Product Manager Alissa Magwood, Country Manager Canada. 📅 October 20–24, 2026 📍 Palais des Congrès de Montréal, Montréal, Québec, Canada 👋 Visit us at Booth #1301 #ASHG2026 #HumanGenetics #Genomics #PrecisionMedicine #GeneticDiagnostics #RareDisease #CENTOGENE

A long-term strategic collaboration for the Middle East & Africa. CENTOGENE and Viafet Laboratories deepen their strategic collaboration, reinforcing our regional presence and our commitment to the healthcare providers, physicians, and partners across the Middle East & Africa. This Cooperation strengthens local capabilities and operational support, while expanding access to CENTOGENE's advanced diagnostic portfolio for the communities we serve. Together, we are building a stronger, lasting collaboration across the region, bringing our expertise, technology, and comprehensive genomic diagnostics closer to the patients and physicians who need them. #CENTOGENE #ViafetLaboratories #StrategicPartnership #MiddleEastAfrica #Genomics #Diagnostics

The test was negative. But the clinical suspicion remained. A 14-year-old patient presented with features suggestive of neurofibromatosis type 1 (NF1). 🚨 Yet previous genetic testing, including conventional WES, had not identified the cause. 💡 CentoXome looked deeper It revealed an intronic NF1 variant that had been missed by previous testing, helping confirm the genetic diagnosis. The finding supported genetic counseling and multidisciplinary surveillance for the patient. With CentoXome, we go beyond conventional WES to uncover what may otherwise remain undetected. #RareDisease #GeneticTesting #WES #PrecisionMedicine #Neurology #Pediatrics

🌍 What an inspiring few days at the 5th MENA Rare Disease Conference in Abu Dhabi! We were honored to take part in the 5th edition of this important gathering, connecting with clinicians, researchers, patient advocates, and industry partners committed to advancing rare disease diagnosis and care across the region. 🏆 A special highlight: CENTOGENE was recognized with the "𝗔𝘄𝗮𝗿𝗱 𝗼𝗳 𝗢𝘂𝘁𝘀𝘁𝗮𝗻𝗱𝗶𝗻𝗴 𝗔𝗰𝗵𝗶𝗲𝘃𝗲𝗺𝗲𝗻𝘁𝘀 𝗶𝗻 𝗥𝗮𝗿𝗲 𝗗𝗶𝘀𝗲𝗮𝘀𝗲𝘀" — a tribute to our team's dedication and to the patients and families who inspire our work every day. Thank you to the organizers, speakers, and everyone who stopped by to connect with us. #MENARDC #RareDisease #CENTOGENE #RareDiseaseAwareness

How certain is your genetic finding? Genetic testing can reveal important findings but sometimes, a finding needs a closer look. When sequencing quality is low or zygosity is unclear, orthogonal confirmation can provide additional evidence. As for certain genetic mechanisms, specialized approaches like RNA/splicing and biochemical profiling methods may be needed. This is where having access to complementary diagnostic methods matters. Because sometimes, a genetic finding calls for another layer of evidence 🔍 #GeneticTesting #Diagnostics #PrecisionMedicine #RareDisease

We're excited to share that CENTOGENE will be attending the 16th European Epilepsy Congress, the leading congress of the International League Against Epilepsy (ILAE) in Europe, in Athens, Greece. As one of the key international events dedicated to epilepsy, this congress brings together healthcare professionals, researchers, and industry leaders to exchange knowledge and explore the latest scientific and clinical advances in epilepsy care. This year, three members of our team will be attending, and we're looking forward to welcoming colleagues and partners at our booth. Our team attending: Miltos Sofianopoulos Tanya Slavova Georgios Bouras We look forward to connecting with colleagues and partners across the epilepsy community and discussing how genetic insights can help advance precision medicine and improve patient outcomes. 📅 September 5–9, 2026 📍 Athens, Greece #EEC2026 #Epilepsy #Neurology #Genetics #PrecisionMedicine #Healthcare #CENTOGENE

We made it to Helsinki, and #SSIEM2026 is going great! Great conversations, new faces, and a lot of enthusiasm for what's next in metabolic disease diagnostics. Are you here too? Come say hi at CENTOGENE booth we'll love to meet you, hear what you're working on, and talk about how genetics can move your work forward. No appointment needed. Just come and say hi. ☕ Tobias Böttcher, Arianda Abazi, Claudia Cozma, Paulo Braga, Steffen Fischer #SSIEM2026 #InbornErrorsOfMetabolism #RareDisease #Genetics #CENTOGENE